Novogene, a leading provider of genomic services and solutions, is excited to announce the adoption of the Olink^® Explore HT platform, further strengthening its multi-omics research capabilities.

With the addition of Olink Explore HT, Novogene now offers advanced next-generation proteomics technology, empowering researchers with unparalleled protein analysis capabilities. This cutting-edge platform allows scientists to accurately measure over 5,400 proteins using just 2µl of sample, streamlining workflows with high automation and enhanced data analysis. Compared to previous generations, Olink Explore HT delivers 80% more unique protein assays, a 4X increase in sample throughput, and a 7X boost in data output.

Olink Explore has already played a pivotal role in large-scale proteomics studies, such as the UK Biobank Pharma Proteomics Project (>50,000 participants) and other population proteomics studies.

" The addition of the Olink Explore platform to the Novogene portfolio marks our commitment to delivering the latest multi-omics solutions to the scientific community in America region," said Justin Lee, Vice President of Novogene. "By seamlessly integrating Olink’s proteomics technology with our existing capabilities in genomics, transcriptomics, metagenomics and epigenomics, we hope to help researchers unlock a new layer of actionable data. This initiative will elevate our ability to provide extraordinary insights into disease biology, paving the way for more impactful discoveries."

Olink also expressed enthusiasm for the collaboration: "We are immensely pleased to see Olink Explore HT being utilized by Novogene, a leading multi-omics service provider, to provide our customers with innovative research services. With the addition of Olink technology, Novogene will be even better positioned to support research across a broad spectrum of therapeutic research fields, helping to improve the understanding of the development, progression, and outcomes of disease."

About Novogene

Novogene is a pioneer in applying cutting-edge molecular biology technologies and high-performance computing to life sciences and human health research. With one of the world’s largest sequencing capacities, Novogene combines deep scientific expertise, exceptional customer service, and industry-leading data quality to help researchers achieve their goals in the rapidly evolving field of genomics. Novogene is committed to becoming your trusted genomics partner.